Malaysian Genomics partners De Cell to bring cell-gene therapy programme to market

Malaysian Genomics Resource Centre Bhd executive chairman Azri Azerai

KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd's (MGRC) wholly-owned subsidiary MGRC Healthcare Sdn Bhd is collaborating with De Cell Bhd for the commercialisation of the former's cell-gene therapy programme.

In a statement, the genomics and biopharmaceutical specialist said it will provide technical and production support to optimise the operational efficiency and market deployment of the EXOGENETIX programme.